RF
BMY icon

Robbins Farley’s Bristol-Myers Squibb BMY Stock Holding History

Robbins Farley’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.5K Sell
721
-182
-20% -$10.5K 0.02% 91
2026
Q1 		$54.8K Hold
903
– – 0.02% 80
2025
Q4 		$48.7K Buy
903
+276
+44% +$13.3K 0.02% 81
2025
Q3 		$28.3K Buy
627
+167
+36% +$7.8K 0.01% 98
2025
Q2 		$21.3K Hold
460
– – 0.01% 102
2025
Q1 		$28.1K Sell
460
-100
-18% -$5.83K 0.01% 88
2024
Q4 		$31.7K Hold
560
– – 0.02% 90
2024
Q3 		$29K Sell
560
-330
-37% -$15.5K 0.01% 89
2024
Q2 		$37K Sell
890
-142
-14% -$6.35K 0.02% 82
2024
Q1 		$56K Buy
1,032
+191
+23% +$9.73K 0.03% 76
2023
Q4 		$43.2K Sell
841
-19
-2% -$997 0.03% 79
2023
Q3 		$49.9K Sell
860
-31,721
-97% -$1.94M 0.03% 78
2023
Q2 		$2.08M Sell
32,581
-1,102
-3% -$73.9K 1.44% 32
2023
Q1 		$2.33M Buy
33,683
+1,449
+4% +$102K 1.56% 30
2022
Q4 		$2.32M Sell
32,234
-11,208
-26% -$845K 1.79% 27
2022
Q3 		$3.09M Sell
43,442
-1,094
-2% -$79.4K 2.54% 11
2022
Q2 		$3.43M Sell
44,536
-6,348
-12% -$483K 3.57% 7
2022
Q1 		$3.72M Sell
50,884
-3,705
-7% -$249K 2.8% 11
2021
Q4 		$3.4M Buy
54,589
+5,083
+10% +$298K 2.52% 16
2021
Q3 		$2.93M Sell
49,506
-5,352
-10% -$352K 2.16% 15
2021
Q2 		$3.67M Buy
54,858
+6,465
+13% +$422K 4.14% 8
2021
Q1 		$3.13M Buy
48,393
+1,682
+4% +$105K 2.76% 10
2020
Q4 		$2.9M Buy
+46,711
New +$2.87M 2.85% 10

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Robbins Farley's BMY Position: Q2 2026 in Review

Robbins Farley reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2026, selling an estimated $10.5K and leaving 721 shares worth $41.5K. The position accounts for 0.02% of the portfolio, ranked #91.

Robbins Farley first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.72M in Q1 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Robbins Farley held 721 shares of Bristol-Myers Squibb worth $41.5K as of Q2 2026.
  • Robbins Farley sold 182 Bristol-Myers Squibb shares in Q2 2026, an estimated $10.5K.
  • Bristol-Myers Squibb made up 0.02% of Robbins Farley's portfolio in Q2 2026, its #91 holding.
  • Robbins Farley first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • Robbins Farley's Bristol-Myers Squibb position peaked at $3.72M in Q1 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Robbins Farley's 13F filing for Q2 2026, filed 23 Jul 2026.